anticoagulants service Flashcards

1
Q

name example oral anticoagulant - direct acting oral anticoagulant

A

Dabigatran
Apixaban
Rivaroxaban
Edoxaban

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

name examples of vitamin K antagonist

A

Warfarin
Phenindione
Acenocoumarol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

name some injectable anticoagulant - lmwh

A
Unfractionated heparin
Enoxaparin - LMWH
Tinzaparin - LMWH
Dalteparin -LWMH
Fondaparinux sodium
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

mechanism of action of warfarin

A

Vitamin K antagonist/vitamin K epoxide reductase inhibition

Acts on multiple coagulation factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

mechanism of action of DOAC

A

Dabigatran is a direct thrombin inhibitor.

Other DOACs act on Factor XA

Similar efficacy to warfarin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

mechanism of action of LMWHs/fondaparinux?

A

LMWHs act on Xa and IIa

Fondaparinux on Xa ONLY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

why are anticoagulants prescribed?

A

PROPHYLAXIS / PREVENTION of:

Deep vein thrombosis (DVT)
Pulmonary embolism (PE)
Mural thrombus (often in ventricle after MI or can be peripheral)

Treatment of acute ST-segment elevation myocardial infarction (STEMI) and Non-ST-segment-elevation myocardial infarction (NON-STEMI), unstable coronary artery disease (LMWH ONLY)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

when is warfarin/ LMWH given

A

Atrial Fibrillation (AF) (all types)
after insertion of prosthetic heart valves
after surgery
clotting disorders (e.g. thrombophilia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

when are DOAC given?

A

after hip or knee replacement surgery

patients with non-valvular AF with one or more other risk factors such as previous stroke, diabetes mellitus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are the advantage and disadvantage of LMWH (low molecular weight heparin)

A

A: rapid onset of action
predictable - dose-dependent plasma level
long half life
in convenience - pre filled syringes

D:
S/C administration: not liked by patients / compliance issues/difficulty with technique/ need for district nurse support/local side effects/disposal of syringes

Complex dosing regimes: depend on patient weight and indication, some expressed as units, some as mg-difficult to prescribe and dispense

Expensive: Clexane (enoxaparin) 40mg/0.4ml solution for injection pre-filled syringes 10=£30.27 1 year=£1105

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are the advantage and disadvantage of warfarin

A

A:

Cheap: 5mg 28=£0.70, 3mg=£0.67 1year ≈£20

Requires INR monitoring ( ≈£200 p/a)

INR monitoring demonstrates efficacy

> 60 years of use

Useful in most situations where oral anticoagulant needed

Specific reversal agent- vitamin K

Tailored to the reason for use and to patient (target INR)

Slow to clear – one missed dose and patient still anticoagulated

Dis:
INR control affected by diet, alcohol, weight loss/gain, illness, medication etc

Wide range of doses

Slow to stabilise INR

Difficult to stabilise in some patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are the advantage and disadvantage of DOACS

A
A:
No monitoring required
Tailored to the reason for use
Few drug/food interactions
Fast time to onset

D:
Expensive: Apixaban 5mg 56=£53.20 1 year = £638.40
Rapid clearance – one missed dose and effects lost
Less experience
Limited product licences
Specific reversal agent for dabigatran Praxbind®(idarucizumab, £2400 per dose) but not others
No test of efficacy
Dabigatran unstable in MDS trays and cannot be crushed (unlicenced use of other DOACs / warfarin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is Warfarin-International Normalized Ratio (INR)

A

An INR test measures how long it takes blood to clot

It is the ratio of the Prothrombin Time (PT) of the subject compared to a normal control

Normal clotting time is 10-14 seconds, with an INR of 1

Time in Therapeutic Range (TTR) = % of timeframe when INR in range (aim>65%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

INR targets

A

depending on how high the risk is to get thrombosis - you are given a different INR target -
higher risk = higher target

low risk = lower target - target = 2.5 and range is 2-3
the people effected:
Atrial Fibrillation (AF)
Venous thromboembolism (VTE)
Bioprosthetic heart valve in mitral position
Bio prosthetic heart valve with additional prothrombotic risk factors e.g. AF

higher risk for thrombus - if they have mechanical aortic valve
target of 3
range 2.5-3.5

highest risk of thrombus -
Recurrent VTE whilst on anticoagulants and control within target range
High risk mechanical prosthetic heart valves e.g. mitral valves
Mechanical prosthetic heart valves with additional prothrombotic risk factors e.g. AF
target of 3.5
range- 3-4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

INR targets

A

depending on how high the risk is to get thrombosis - you are given a different INR target -
higher risk = higher target

low risk = lower target - target = 2.5 and range is 2-3
the people effected:
Atrial Fibrillation (AF)
Venous thromboembolism (VTE)
Bioprosthetic heart valve in mitral position
Bio prosthetic heart valve with additional prothrombotic risk factors e.g. AF

higher risk for thrombus - if they have mechanical aortic valve
target of 3
range 2.5-3.5

highest risk of thrombus -
Recurrent VTE whilst on anticoagulants and control within target range
High risk mechanical prosthetic heart valves e.g. mitral valves
Mechanical prosthetic heart valves with additional prothrombotic risk factors e.g. AF
target of 3.5
range- 3-4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Aims of pharmacist led anticoagulation services

A

Offer standardised, clinically effective and safe monitoring and management of patients on anticoagulants in the community

Ensure patients have access to a convenient, local service and reduced waiting times

Provide warfarin patients with INR tests using ‘Point of Care Testing’ device-instant results and less invasive fingerprick test compared to phlebotomy

Improve patient understanding of and compliance with their treatment by providing ongoing education, support and a one-stop service

17
Q

what service is given to patients on warfarin

A

Advice on administration, side effects, etc

Testing of INR using Point of Care Testing (POCT) equipment e.g. Coaguchek (Roche®)

Management of warfarin dose

Referral to anticoagulation clinic/ GP if outside scope of POCT service

Supplying warfarin on Patient Group Direction (PGD)/ Patient Specific Direction

(PSD) or on prescription from GP

‘Bridging’ service between being on LMWH during hospital admission/ resuming oral warfarin on discharge until patient INR in range

Visiting housebound patients and INR testing in patients’ homes

Supporting self testing patients

18
Q

what is the services provided for patients on DOAC

A

Advice on adherence, side effects, lifestyle impact of anticoagulants, et

19
Q

Which warfarin patients use the pharmacy led service?

A

Referred by GPs or hospital anticoagulation team
Adults
Usually stable long term patients
Usually complex high risk patients excluded, e.g. pregnancy, GI bleed in the last 6 months (medical records not available to pharmacists)
Patient choice

20
Q

Pharmacy led anticoagulation services
Anticoagulation service requires good communication between stakeholders
who are the stakeholders

A

= GP
=Anticoagulation pharmacist (Fingerprick blood testing)
=Hospital anticoagulation Clinic (Venous blood testing)

21
Q

Pharmacist Led service

A

After receiving a referral:

Book patient into the pharmacist led anticoagulation clinic
At the first appointment:

Introduce self, check patient ID, add patient details to INRStar/DAWN

Check informed consent to pharmacist led service

Discussion tailored to patient’s needs and level of understanding (Accessible Information Standard 2016) on:
Yellow book, warfarin tablets, importance of managing blood INR level within their therapeutic range
Risks of not doing so
Factors affecting INR e.g. drug interactions, illness, diet, alcohol
Hospital admissions, dental or surgical treatment
Side effects and how to deal with bleeding episodes
Who to contact with concerns or queries

Summarise important points

Document everything

22
Q

how to carry out INR test

A

Clean area with alcohol wipes
Wash hands, put on gloves
Get patient to wash hands with warm water and dry
Take capillary blood sample –use disposable lancet
Analyse sample using Coaguchek XS Pro II
Clean area and equipment

Input INR data into INRStar/DAWN – amend dose of warfarin-use program/ knowledge/ judgement
Next test date calculated by INRStar/DAWN (or work out from patient risk factors/ change to INR). Inform patient
Copy of INRStar/DAWN printout to patient and update yellow book
Inform GP / anticoagulant clinic of result (if required

23
Q

what can be the causes of INR being out of therapeutic range

A

Missed tablets?
Been unwell (diarrhoea, a stay in hospital, tests or interventions)?
Had lifestyle changes that affect daily routine?
Changed or started any prescription or OTC medicine, vitamins/ herbal remedies?

Made any major dietary / alcohol changes / celebration e.g.
Crash diets
Binge eating
Marked changes in alcohol consumption

Been on holiday?
Had any kind of trauma / injury?

Had any unexpected bruising or bleeding, e.g
Prolonged bleeding from cuts
Nose bleeds
Bleeding gums
Red or dark brown urine
Red or black stools (black tar-like stools)
For women, increased bleeding during periods (or any other vaginal bleeding)